Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Kinnate Biopharma Inc.

    NASDAQ: KNTE · Real-Time Price · USD
    2.65
    -0.01 (-0.38%)
    At close: Apr 02, 2024, 10:00 PM

    Kinnate Biopharma Statistics

    Share Statistics

    Kinnate Biopharma has 47.17M shares outstanding. The number of shares has increased by 0% in one year.

    Shares Outstanding

    n/a
    		 47.17M

    Shares Change (YoY)

    n/a
    		 0%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 22.68M

    Failed to Deliver (FTD) Shares

    n/a
    		 116,752

    FTD / Avg. Volume

    n/a
    		 31.8%

    Short Selling Information

    Short Interest

    n/a
    		 n/a

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 n/a

    Short Ratio (days to cover)

    n/a
    		 n/a

    Valuation Ratios

    The PE ratio is -0.98 and the forward PE ratio is null. Kinnate Biopharma's PEG ratio is 0.15.

    PE Ratio

    n/a
    		 -0.98

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 0.69

    P/FCF Ratio

    n/a
    		 -1.1

    PEG Ratio

    n/a
    		 0.15
    Financial Ratio History

    Enterprise Valuation

    Kinnate Biopharma has an Enterprise Value (EV) of 56.56M.

    EV / Sales

    n/a
    		 0

    EV / EBITDA

    n/a
    		 -0.48

    EV / EBIT

    n/a
    		 -0.57

    EV / FCF

    n/a
    		 -0.57

    Financial Position

    The company has a current ratio of 13.19, with a Debt / Equity ratio of 0.02.

    Current Ratio

    n/a
    		 13.19

    Quick Ratio

    n/a
    		 13.19

    Debt / Equity

    n/a
    		 0.02

    Debt / EBITDA

    n/a
    		 -0.03

    Debt / FCF

    n/a
    		 -0.03

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is -70.7% and Return on Invested Capital is -73.23%.

    Return on Equity

    n/a
    		 -70.7%

    Return on Assets

    n/a
    		 -64.89%

    Return on Invested Capital

    n/a
    		 -73.23%

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,341,059.52

    Employee Count

    n/a
    		 84

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by 0% in the last 52 weeks. The beta is 1.34, so Kinnate Biopharma's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.34

    52-Week Price Change

    n/a
    		 n/a

    50-Day Moving Average

    n/a
    		 2.49

    200-Day Moving Average

    n/a
    		 2.27

    Relative Strength Index (RSI)

    n/a
    		 62.67

    Average Volume (20 Days)

    n/a
    		 367,164

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 -799K

    Operating Income

    n/a
    		 -119.01M

    Net Income

    n/a
    		 -112.65M

    EBITDA

    n/a
    		 -118.21M

    EBIT

    n/a
    		 n/a

    Earnings Per Share (EPS)

    n/a
    		 -2.42
    Full Income Statement

    Balance Sheet

    The company has 57M in cash and 3.17M in debt, giving a net cash position of 53.82M.

    Cash & Cash Equivalents

    n/a
    		 57M

    Total Debt

    n/a
    		 3.17M

    Net Cash

    n/a
    		 53.82M

    Retained Earnings

    n/a
    		 -372.01M

    Total Assets

    n/a
    		 173.6M

    Working Capital

    n/a
    		 146.18M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -100.04M and capital expenditures 0, giving a free cash flow of -100.04M.

    Operating Cash Flow

    n/a
    		 -100.04M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -100.04M

    FCF Per Share

    n/a
    		 -2.15
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    KNTE does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 -102.05%

    FCF Yield

    n/a
    		 -90.63%
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for KNTE.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 0.96

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist